A clinical trial of combination neoadjuvant chemotherapy and transoral robotic surgery in patients with T3 and T4 laryngo-hypopharyngeal cancer
Annals of Surgical Oncology Mar 11, 2018
Park YM, et al. - A prospective clinical trial of combination neoadjuvant chemotherapy and transoral robotic surgery (TORS) was conducted in patients with locally advanced laryngo-hypopharyngeal cancer. This therapy resulted in favorable oncologic outcomes and preserved organ functionalities in T3–T4 laryngo-hypopharyngeal cancer.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
